Natpara Logo
Natpara Logo

For patients with hypoparathyroidism

What is the right
calcium balance?

Find out how NATPARA was able to affect serum calcium levels as an adjunct to calcium and vitamin D in patients with hypoparathyroidism1

Find out how NATPARA was able to affect serum calcium levels as an adjunct to calcium and vitamin D in patients with hypoparathyroidism1

NATPARA is a once-daily, self-administered injectable parathyroid hormone1

See How It Works

Could one of your patients be appropriate for NATPARA?

Learn More

Ready to prescribe
NATPARA?

Get Started

Attend a Speaker Event

Join your colleagues for an educational program about hypoparathyroidism and NATPARA

{{event.StartDate}}

{{event.VenueName}}
{{event.VenueAddress}}
{{event.VenueCity}}, {{event.VenueState}} {{event.VenueZip}}

{{event.StartTime}} - {{event.EndTime}} {{event.TimeZone}}

Reference: 1. NATPARA [package insert]. Shire-NPS Pharmaceuticals, Inc.

This product information is intended for US Healthcare Professionals only.

NATPARA® is a registered trademark of Shire-NPS Pharmaceuticals, Inc.

OnePath® is a registered trademark of Shire or its affiliates.

Q-Cliq is a trademark of Shire-NPS Pharmaceuticals, Inc.

SHIRE and the Shire logo are trademarks or registered trademarks of Shire Pharmaceutical Holdings Ireland Limited or its affiliates.